PRL3 induces polypoid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
10.1038/s42003-021-02449-8
Saved in:
Main Authors: | Thura, Min, Ye, Zu, Al-Aidaroos, Abdul Qader, Xiong, Qiancheng, Ong, Jun Yi, Gupta, Abhishek, Li, Jie, Guo, Ke, Ang, Koon Hwee, Zeng, Qi |
---|---|
Other Authors: | BIOCHEMISTRY |
Format: | Article |
Published: |
Nature Research
2022
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/231925 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Erratum: Author Correction: PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse (Communications biology (2021) 4 1 (923))
by: Thura, Min, et al.
Published: (2022) -
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
by: Thura, Min, et al.
Published: (2019) -
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
by: Thura M., et al.
Published: (2020) -
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)
by: Thura, Min, et al.
Published: (2021) -
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
by: Chee, Cheng E, et al.
Published: (2023)